Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-12 4:40 pm Purchase | 2022-07-08 | 13G | ESSA Pharma Inc. EPIX | BIOTECHNOLOGY VALUE FUND L P | 8,748,629 19.900% | 4,183,387![]() (+91.64%) | Filing History |
| 2022-07-11 5:03 pm Purchase | 2022-06-29 | 13G | 89bio, Inc. ETNB | BIOTECHNOLOGY VALUE FUND L P | 3,898,000 9.990% | 3,898,000![]() (New Position) | Filing History |
| 2022-06-21 4:53 pm Purchase | 2022-06-16 | 13G | 4D Molecular Therapeutics, Inc. FDMT | BIOTECHNOLOGY VALUE FUND L P | 4,007,413 12.400% | 2,001,551![]() (+99.79%) | Filing History |
| 2022-06-16 5:24 pm Purchase | 2022-06-06 | 13G | Centessa Pharmaceuticals plc CNTA | BIOTECHNOLOGY VALUE FUND L P | 6,894,345 7.300% | 6,894,345![]() (New Position) | Filing History |
| 2022-06-06 5:25 pm Purchase | 2022-06-02 | 13G | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 8,141,988 19.400% | 3,283,227![]() (+67.57%) | Filing History |
| 2022-06-01 5:00 pm Purchase | 2022-05-27 | 13D | Kymera Therapeutics, Inc. KYMR | BIOTECHNOLOGY VALUE FUND L P | 4,138,758 8.000% | 552,100![]() (+15.39%) | Filing History |
| 2022-05-26 5:09 pm Purchase | 2022-05-16 | 13G | Annexon, Inc. ANNX | BIOTECHNOLOGY VALUE FUND L P | 3,343,194 8.700% | 3,343,194![]() (New Position) | Filing History |
| 2022-05-02 5:02 pm Purchase | 2022-04-22 | 13G | iTeos Therapeutics, Inc. ITOS | BIOTECHNOLOGY VALUE FUND L P | 1,929,201 5.400% | 1,929,201![]() (New Position) | Filing History |
| 2022-05-02 4:59 pm Purchase | 2022-04-22 | 13G | IDEAYA Biosciences, Inc. IDYA | BIOTECHNOLOGY VALUE FUND L P | 1,964,859 5.100% | 1,964,300![]() (+351395.35%) | Filing History |
| 2022-04-18 4:49 pm Purchase | 2022-04-05 | 13D | MoonLake Immunotherapeutics MLTX | BIOTECHNOLOGY VALUE FUND L P | 21,751,284 58.900% | 21,751,284![]() (New Position) | Filing History |
| 2022-04-04 4:38 pm Purchase | 2022-03-25 | 13G | AN2 Therapeutics, Inc. ANTX | BIOTECHNOLOGY VALUE FUND L P | 1,616,665 8.600% | 1,616,665![]() (New Position) | Filing History |
| 2022-03-24 4:22 pm Purchase | 2022-03-14 | 13G | Tyra Biosciences, Inc. TYRA | BIOTECHNOLOGY VALUE FUND L P | 2,472,327 5.900% | 2,472,327![]() (New Position) | Filing History |
| 2022-03-18 7:18 pm Sale | 2021-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | BIOTECHNOLOGY VALUE FUND L P | 4,305,540 8.200% | -851,946![]() (-16.52%) | Filing History |
| 2022-03-14 4:48 pm Purchase | 2022-03-03 | 13G | Arcus Biosciences, Inc. RCUS | BIOTECHNOLOGY VALUE FUND L P | 3,960,948 5.600% | 1,208,726![]() (+43.92%) | Filing History |
| 2022-02-14 2:01 pm Sale | 2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ | BIOTECHNOLOGY VALUE FUND L P | 6,353,645 7.100% | -2,030,000![]() (-24.21%) | Filing History |
| 2022-02-14 1:56 pm Purchase | 2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | BIOTECHNOLOGY VALUE FUND L P | 92,583 9.990% | 22,563![]() (+32.22%) | Filing History |
| 2022-02-14 1:53 pm Purchase | 2021-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | BIOTECHNOLOGY VALUE FUND L P | 5,157,486 9.990% | 1,658,140![]() (+47.38%) | Filing History |
| 2022-02-14 1:51 pm Purchase | 2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | BIOTECHNOLOGY VALUE FUND L P | 2,202,315 9.990% | 2,202,315![]() (New Position) | Filing History |
| 2022-02-14 1:49 pm Purchase | 2021-12-31 | 13G | PHAXIAM Therapeutics S.A. PHXM | BIOTECHNOLOGY VALUE FUND L P | 51,192 16.500% | 10,372![]() (+25.41%) | Filing History |
| 2022-02-14 1:46 pm Purchase | 2021-12-31 | 13G | Elevation Oncology, Inc. ELEV | BIOTECHNOLOGY VALUE FUND L P | 1,611,698 6.900% | 1,611,698![]() (New Position) | Filing History |

